Advances and Prospects in Cancer Immunotherapy. (13th March 2014)

• Record Type: Journal Article
• Authors: Zhou, Juhua
• Other Names: Camps Jordi Academic Editor.
• Is Part Of: New journal of science. Volume 2014(2014)
• Publication Date: 2014-03-13
• Subjects: Life sciences -- Periodicals; Life sciences; Electronic journals; Periodicals; 500
• DOI: 10.1155/2014/745808
• Languages: English
• ISSNs: 2356-7740

Abstract

Abstract : Cancer immunotherapy is a promising and effective treatment modality for patients with cancers. Cytokine, anticytokine, and antibody therapies appear to be effective in treating various forms of cancer. The human papillomavirus vaccine is protective for cervical cancer, and this discovery has paved the way to the development of cancer vaccines for other forms of virus-associated cancers such as liver cancer and Merkel cell carcinoma. Clinical trials have demonstrated that adoptive cell therapy using tumor-infiltrating lymphocytes can induce tumor regression in approximately 75% of metastatic melanoma patients, suggesting the possibility of using similar technique to effectively treat breast, lung, and renal cancers in the near future. Besides, genetically engineered T cells transduced with genes encoding specific T cell receptors and chimeric antigen receptors have been shown effective in the treatment of cancer patients. These studies suggest that combination therapies are superior choices in cancer immunotherapy for patients.